# "PTHrP(1-36) IV Dose Escalation Study"

> **NCT00177411** · PHASE1 · WITHDRAWN · sponsor: **University of Pittsburgh**

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Parathyroid Hormone-related Protein

## Key facts

- **NCT ID:** NCT00177411
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-07
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Protocol design was changed so it no longer fit the description of this study.
- **Last updated:** 2014-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00177411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00177411, ""PTHrP(1-36) IV Dose Escalation Study"". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00177411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*